Avaxia Biologics, Inc.

Avaxia Biologics develops orally-delivered antibody products for disease targets accessible via the GI tract.

  • Stage Not Set
  • Industry Biotechnology
  • Location Burlington, MA, USA
  • Currency USD
  • Employees 3
  • Website avaxiabiologics.com

Company Summary

Team

  • Barbara Fox
    CEO

  • Anne Baia
    CFO

  • Eileen Bostwick
    VP Product Development

  • Barbara Fox

Advisors

  • Lewis Geffen, MintzLevin; Darlene Vanstone, Elmore Patent Group
    Lawyer
    Unconfirmed

Previous Investors

  • Jonathan Fleming |David Poorvin, PhD|Management, other individuals
    Unconfirmed

Starting a startup?

Join the world's largest startup network for guidance, tools, and fundraising opportunities.

Get Started for Free